.

Pharmaceutical Business Intelligence

  • Find generic sources and suppliers
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

CORZIDE Drug Profile

« Back to Dashboard

Which patents cover Corzide, and what substitute generic drugs are available?

Corzide is a drug marketed by King Pharms and is included in one NDA.

The generic ingredient in CORZIDE is bendroflumethiazide; nadolol. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the bendroflumethiazide; nadolol profile page.

Summary for Tradename: CORZIDE

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list33
Patent Applications: see list2,897
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CORZIDE at DailyMed

Pharmacology for Tradename: CORZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
King Pharms
CORZIDE
bendroflumethiazide; nadolol
TABLET;ORAL018647-001May 25, 1983RXYesNo► Subscribe► Subscribe
King Pharms
CORZIDE
bendroflumethiazide; nadolol
TABLET;ORAL018647-002May 25, 1983RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: CORZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
King Pharms
CORZIDE
bendroflumethiazide; nadolol
TABLET;ORAL018647-001May 25, 19833,935,267► Subscribe
King Pharms
CORZIDE
bendroflumethiazide; nadolol
TABLET;ORAL018647-001May 25, 19833,982,021► Subscribe
King Pharms
CORZIDE
bendroflumethiazide; nadolol
TABLET;ORAL018647-002May 25, 19833,982,021► Subscribe
King Pharms
CORZIDE
bendroflumethiazide; nadolol
TABLET;ORAL018647-002May 25, 19833,935,267► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc